DPP4 and pancreatitis: However, there is keen interest founded in development of novel DPP-4 inhibitor as some of the marketed drugs have adverse effects such as gastrointestinal problems, skin reactions and majorly high risk of developing pancreatitis have been observed experiencing severe pain in upper abdomen.